- Home
- Publications
- Publication Search
- Publication Details
Title
Lupus nephritis and B-cell targeting therapy
Authors
Keywords
-
Journal
Expert Review of Clinical Immunology
Volume 13, Issue 10, Pages 951-962
Publisher
Informa UK Limited
Online
2017-08-12
DOI
10.1080/1744666x.2017.1366855
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Successful treatment of refractory lupus nephritis by the sequential use of rituximab and belimumab
- (2017) Federico Simonetta et al. JOINT BONE SPINE
- Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence
- (2017) Savino Sciascia et al. RHEUMATOLOGY INTERNATIONAL
- Use of Rituximab in Systemic Lupus Erythematosus: A Single Center Experience Over 14 Years
- (2017) R. Aguiar et al. ARTHRITIS CARE & RESEARCH
- Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials
- (2017) Megan E. B. Clowse et al. Arthritis & Rheumatology
- Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus
- (2017) Richard Furie et al. Arthritis & Rheumatology
- Btk inhibition treats TLR7/IFN driven murine lupus
- (2016) Andrew T. Bender et al. CLINICAL IMMUNOLOGY
- Optimising B-cell depletion in autoimmune disease: is obinutuzumab the answer?
- (2016) Venkat Reddy et al. DRUG DISCOVERY TODAY
- Bortezomib treatment prevents glomerulosclerosis associated with lupus nephritis in a murine model through suppressive effects on the immune and renin–angiotensin systems
- (2016) Yuko Matsuki-Muramoto et al. Modern Rheumatology
- Plasma cells as an innovative target in autoimmune disease with renal manifestations
- (2016) Falk Hiepe et al. Nature Reviews Nephrology
- Fostamatinib, an oral spleen tyrosine kinase inhibitor, in the treatment of rheumatoid arthritis: a meta-analysis of randomized controlled trials
- (2016) Sumit Kunwar et al. RHEUMATOLOGY INTERNATIONAL
- Therapeutic Blockade of Immune Complex-Mediated Glomerulonephritis by Highly Selective Inhibition of Bruton’s Tyrosine Kinase
- (2016) Samantha A. Chalmers et al. Scientific Reports
- Post Hoc Analysis of the Phase II/III APRIL-SLE Study: Association Between Response to Atacicept and Serum Biomarkers Including BLyS and APRIL
- (2016) Caroline Gordon et al. Arthritis & Rheumatology
- Tofacitinib Ameliorates Murine Lupus and Its Associated Vascular Dysfunction
- (2016) Yasuko Furumoto et al. Arthritis & Rheumatology
- Follicular Helper T Cells in Systemic Lupus Erythematosus: Why Should They Be Considered as Interesting Therapeutic Targets?
- (2016) Matthieu Sawaf et al. Journal of Immunology Research
- Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome
- (2016) Sigrid Lunde et al. PLoS One
- Intravital imaging reveals improved Kupffer cell-mediated phagocytosis as a mode of action of glycoengineered anti-CD20 antibodies
- (2016) Capucine L. Grandjean et al. Scientific Reports
- The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus
- (2015) Tobias Alexander et al. ANNALS OF THE RHEUMATIC DISEASES
- A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE)
- (2015) Kenneth C Kalunian et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study
- (2015) D A Isenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Proteasome inhibitors
- (2015) Beverly A. Teicher et al. BIOCHEMICAL PHARMACOLOGY
- Rituximab in the treatment of autoimmune haemolytic anaemia
- (2015) Chaturaka Rodrigo et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Case report: successful treatment of membranous lupus nephritis with belimumab in an African female immigrant
- (2015) Marie-Angélique De Scheerder et al. CLINICAL RHEUMATOLOGY
- Correlation of disease activity in proliferative glomerulonephritis with glomerular spleen tyrosine kinase expression
- (2015) Stephen P. McAdoo et al. KIDNEY INTERNATIONAL
- Associations between the functional CD40 rs4810485 G/T polymorphism and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis
- (2015) Y H Lee et al. LUPUS
- First-in-human trial of the safety, pharmacokinetics and immunogenicity of a PEGylated anti-CD40L antibody fragment (CDP7657) in healthy individuals and patients with systemic lupus erythematosus
- (2015) A Tocoian et al. LUPUS
- Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus
- (2015) D C Salazar-Camarena et al. LUPUS
- Longer duration of B cell depletion is associated with better outcome
- (2015) Sofia Sapeta Dias et al. RHEUMATOLOGY
- The Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus Nephritis
- (2015) Marcus R. Clark et al. SEMINARS IN NEPHROLOGY
- CDP7657, an anti-CD40L antibody lacking an Fc domain, inhibits CD40L-dependent immune responses without thrombotic complications: an in vivo study
- (2015) Anthony Shock et al. ARTHRITIS RESEARCH & THERAPY
- Internalization of Rituximab and the Efficiency of B Cell Depletion in Rheumatoid Arthritis and Systemic Lupus Erythematosus
- (2015) Venkat Reddy et al. Arthritis & Rheumatology
- Disturbed T Cell Signaling and Altered Th17 and Regulatory T Cell Subsets in the Pathogenesis of Systemic Lupus Erythematosus
- (2015) Nils Rother et al. Frontiers in Immunology
- Bortezomib Plus Continuous B Cell Depletion Results in Sustained Plasma Cell Depletion and Amelioration of Lupus Nephritis in NZB/W F1 Mice
- (2015) Laleh Khodadadi et al. PLoS One
- A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study
- (2014) R A Furie et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)
- (2014) David Isenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Fc -receptor-mediated trogocytosis impacts mAb-based therapies: historical precedence and recent developments
- (2014) R. P. Taylor et al. BLOOD
- Expression of the inhibitory Fc gamma receptor IIB (FCGR2B, CD32B) on follicular lymphoma cells lowers the response rate to rituximab monotherapy (SAKK 35/98)
- (2014) Chern Siang Lee et al. BRITISH JOURNAL OF HAEMATOLOGY
- Spleen Tyrosine Kinase Inhibition Attenuates Autoantibody Production and Reverses Experimental Autoimmune GN
- (2014) S. P. McAdoo et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Impact of rituximab on height and weight in children with refractory steroid-dependent nephrotic syndrome
- (2014) Mai Sato et al. PEDIATRIC NEPHROLOGY
- Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis
- (2014) Federico Alberici et al. RHEUMATOLOGY
- Ofatumumab: a novel treatment for severe systemic lupus erythematosus
- (2014) C. C. Thornton et al. RHEUMATOLOGY
- Immunopathology of lupus nephritis
- (2014) Hans-Joachim Anders et al. Seminars in Immunopathology
- Treatment of Lupus Nephritis With Abatacept: The Abatacept and Cyclophosphamide Combination Efficacy and Safety Study
- (2014) Arthritis & Rheumatology
- A Single Dose of Rituximab Does Not Deplete B Cells in Secondary Lymphoid Organs but Alters Phenotype and Function
- (2013) E. G. Kamburova et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids
- (2013) Marie B Condon et al. ANNALS OF THE RHEUMATIC DISEASES
- An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's)
- (2013) Carol A Langford et al. ANNALS OF THE RHEUMATIC DISEASES
- Suppression of Glomerulonephritis in Lupus-Prone NZB × NZW Mice by RN486, a Selective Inhibitor of Bruton's Tyrosine Kinase
- (2013) Paola Mina-Osorio et al. ARTHRITIS AND RHEUMATISM
- Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, Double-Blind, Phase III Study
- (2013) Eduardo F. Mysler et al. ARTHRITIS AND RHEUMATISM
- Immunoserological parameters in SLE: high-avidity anti-dsDNA detected by ELISA are the most closely associated with the disease activity
- (2013) Sladjana Andrejevic et al. CLINICAL RHEUMATOLOGY
- The BAFF/APRIL system: Emerging functions beyond B cell biology and autoimmunity
- (2013) Fabien B. Vincent et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Selective Inhibition of BTK Prevents Murine Lupus and Antibody-Mediated Glomerulonephritis
- (2013) A. L. Rankin et al. JOURNAL OF IMMUNOLOGY
- Disease Control and Safety of Belimumab Plus Standard Therapy Over 7 Years in Patients with Systemic Lupus Erythematosus
- (2013) E. M. Ginzler et al. JOURNAL OF RHEUMATOLOGY
- B cell biology: implications for treatment of systemic lupus erythematosus
- (2013) JH Anolik LUPUS
- Rituximab in systemic lupus erythematosus: an updated systematic review and meta-analysis
- (2013) B Duxbury et al. LUPUS
- Impact of rituximab trials on the treatment of ANCA-associated vasculitis
- (2013) F. Alberici et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Serum rituximab levels and efficiency of B cell depletion: differences between patients with rheumatoid arthritis and systemic lupus erythematosus
- (2013) V. Reddy et al. RHEUMATOLOGY
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice
- (2012) L. P. Kil et al. BLOOD
- CD22 and Autoimmune Disease
- (2012) Thomas Dörner et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Multicenter longitudinal study of B-lymphocyte depletion in refractory systemic lupus erythematosus: the LESIMAB study
- (2012) A Fernández-Nebro et al. LUPUS
- Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE
- (2012) MA Dooley et al. LUPUS
- The Proteasome Inhibitor Bortezomib Prevents Lupus Nephritis in the NZB/W F1 Mouse Model by Preservation of Glomerular and Tubulointerstitial Architecture
- (2012) Nadine Hainz et al. NEPHRON EXPERIMENTAL NEPHROLOGY
- Modulating proximal cell signaling by targeting Btk ameliorates humoral autoimmunity and end-organ disease in murine lupus
- (2012) Jack Hutcheson et al. ARTHRITIS RESEARCH & THERAPY
- Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial
- (2012) Ellen M Ginzler et al. ARTHRITIS RESEARCH & THERAPY
- B cell biomarkers of rituximab responses in systemic lupus erythematosus
- (2011) Edward M. Vital et al. ARTHRITIS AND RHEUMATISM
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: Pooled data from European cohorts
- (2011) Cándido Díaz-Lagares et al. AUTOIMMUNITY REVIEWS
- Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacy
- (2011) S. H. Lim et al. BLOOD
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- BAFF and selection of autoreactive B cells
- (2011) Zheng Liu et al. TRENDS IN IMMUNOLOGY
- Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring
- (2011) Christine Hsieh et al. ARTHRITIS CARE & RESEARCH
- Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry
- (2010) Benjamin Terrier et al. ARTHRITIS AND RHEUMATISM
- Constitutive activation of Bruton's tyrosine kinase induces the formation of autoreactive IgM plasma cells
- (2010) Rogier Kersseboom et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- In Situ B Cell-Mediated Immune Responses and Tubulointerstitial Inflammation in Human Lupus Nephritis
- (2010) A. Chang et al. JOURNAL OF IMMUNOLOGY
- Rituximab: Mechanism of Action
- (2010) George J. Weiner SEMINARS IN HEMATOLOGY
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Total and biologically active CD154 in patients with SLE
- (2009) Juan B. de Sanctis et al. AUTOIMMUNITY
- Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritis
- (2009) Thomas Dörner et al. AUTOIMMUNITY REVIEWS
- Rituximab in Severe Lupus Nephritis: Early B-Cell Depletion Affects Long-Term Renal Outcome
- (2009) C. Melander et al. Clinical Journal of the American Society of Nephrology
- Bruton’s tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain
- (2009) Abdalla J. Mohamed et al. IMMUNOLOGICAL REVIEWS
- Serum Levels of Soluble CD40 Ligand at Flare and at Remission in Patients with Systemic Lupus Erythematosus
- (2009) M. URQUIZU-PADILLA et al. JOURNAL OF RHEUMATOLOGY
- Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus
- (2008) D Albert et al. ANNALS OF THE RHEUMATIC DISEASES
- An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus
- (2008) Frances Rena Bahjat et al. ARTHRITIS AND RHEUMATISM
- Altered B cell receptor signaling in human systemic lupus erythematosus
- (2008) Scott A. Jenks et al. AUTOIMMUNITY REVIEWS
- The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis
- (2008) Kirsten Neubert et al. NATURE MEDICINE
- Relapsed Wegener's granulomatosis after rituximab therapy--B cells are present in new pathological lesions despite persistent 'depletion' of peripheral blood
- (2008) A. J. Ferraro et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started